
ãªãããã»ã©å°ãªãå»åž«ãããCOVIDãšãã®ã¯ã¯ãã³ã«é¢ããçå®ãèªãåæ°ãæãŠãªãã£ãã®ãïŒ
å èšäºã¯ãã¡ããã/Click here to read the original article.
ç«ææ¥ããã€ãªãŒã»ã¡ãŒã«çŽã¯æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®åŸã«çºçããæ°åä»¶ã®æšªææ§èé«çïŒTMïŒçäŸã«é¢ããèšäºãæ²èŒãããããã¯èé«ã«ççãåŒãèµ·ããçšãªç¥çµçŸæ£ã§ãããèšäºã§ã¯ã2020幎12æã«ã¢ãã«ã補ã¯ã¯ãã³ã®1åæ¥çš®ãåããæ°æ¥åŸã«TMãçºçã麻çºç¶æ ãšãªã£ãç±³åœäººæŽåœ¢å€ç§å»ãžã§ãšã«ã»ãŠã©ã«ã¹ã³ã°å»åž«ã®äºäŸã玹ä»ãããã
ããããäºäŸãå±éºã®å åã§ããã«ãããããããå»åž«ãã¡ãæ£è ã«ãã¯ã¯ãã³æ¥çš®ãåããããšç±å¿ã«å§ããã®ã¯ãªãã ãããïŒããŒãã³ã»ã³ãŒã«ãã³å士ãä»å¹Žåãã«çºè¡šããèæžã§ã¯ãå€ãã®å»åž«ããã¯ã¯ãã³ãã«é¢ããçå®ã«ã€ããŠæ²é»ãå®ã£ãã®ã¯ã人ã ã«æ³šå°ãæã€ããšã§é«é¡ãªå ±é ¬ãåŸãŠãããããããã¯å»ççã®æš©åšã«å察ããã®ãæããŠããããã ãšç€ºåããŠããã
ãããå€ãã®å»åž«ãã³ããã®çå®ãèªããªãã£ãçç±ãïŒïŒçœªãªãè ãžã®æ®é ·ãªè¿«å®³
ããŒãã³ã»ã³ãŒã«ãã³å士
ç¥æ§ããå»åž«ãç§åŠè ãã¡ã®éã§ã¯ãCOVID-19ã®ãããšåœã®ãã³ãããã¯ãå±éãããéããªãããã»ã©å€ãã®å»åž«ãèªãããåã«ã€ããŠæ²é»ãå®ã£ãã®ãã倧ããªå°æãåºãã£ãŠããã
ã§ã¯ããªãããã»ã©å€ãã®å»åž«ãCOVID-19ã¯ã¯ãã³ã«ã€ããŠæ²é»ãå®ãããããŸã§åžå Žã«åºåã£ãäžã§æãå±éºã§æå®³ãªåäžã®å»è¬åãšæ£ç¢ºã«è©ããã補åãåŠæ¹ãç¶ããã®ãïŒCOVID-19ã¯ã¯ãã³ã¯æš©åšãçŽæãã广ãçºæ®ãããåæã«æ¥çš®ãåããæ£è ã®äžã§æ°ããããªãã»ã©ã®æ»è ãé節ãªè¢«å®³è ãåºããã
ããã»ã©å€ãã®å»åž«ã蚌æ ãç¡èŠããå»ççå éšã®äžæ£ãªå©èšè ãè²·åããããžã£ãŒããªã¹ãã»æåäººã®æç€ºã«åŸã£ãäºå®ã«ã¯ãäºã€ã®èª¬æãããã
第äžã®èª¬æã¯ãäžçäžã®å»åž«ãCOVID-19ã¯ã¯ãã³æ¥çš®ã«å¯ŸããŠç°åžžã«é«é¡ãªå ±é ¬ãåŸãŠããããšã ãç é¢ã«ã¯è³è³ïŒããŒãã¹ãšç§°ãããïŒãæ¯æããããã®é¡ã¯æ¥çš®æ£è æ°ã«æ¯äŸããŠãããå»åž«ãã¡ã¯ãéåžžã®æ¥çš®å ±é ¬ãå€§å¹ ã«äžåãå ±é ¬ã§è²·åãããé床ãªçåãåããããšãæããšã©ãŸããããããããããããã®å»åž«ã¯æ³å»·ã«ç«ã€ããšã«ãªãããããã§äœããã®åŒæãããããšã¯äžå¯èœã ããã圌ããéå°éçãã€è²ªæ¬²ã«æ¯ãèã£ããšèšãã®ã¯ã倧ãããªè¡šçŸã§ã¯ãªãã
第äºã®èª¬æã¯ãå»åž«ãã¡ãå»ççã®æš©åšã«ç°è°ãå±ããããšãæããŠããç¹ã«ããããªããªããååãäžè¬åžæ°ã«æèŠã衚æããå»åž«ãã¡ããå ¬çå èš±æ©é¢ã«ãã£ãŠå èš±ãå¥å¥ªãããããã«ã¡ãã£ã¢ã«ãã£ãŠäžå·ããããšããçµæ«ãç®ã®åœããã«ããŠããããã ã
éå»3幎éå·§åŠã«é èœãããŠããçå®ã¯ãå»ççãæ°å幎ã«ãããè£œè¬æ¥çã«æ¯é ãããäžçäžã®å èš±åœå±ãäºå®ãæ€èšŒããæç€ºéãã«åããããšã ãçå®ãèªãããšããæ°å€ãã®å»åž«ãå èš±ãšçèšã倱ã£ãã倧倿°ã®å»åž«ã¯ãçºèšããè ãã¡ã«èµ·ããäºæ ãç®ã®åœããã«ããæ²é»ãå®ããæ£è ãšèªåèªèº«ããããŠè·æ¥ãè£åã£ãããã®è °æãã©ãã¯æ¥ãç¥ãã¹ãã ã
è±åœã§ã¯å»åž«å èš±ã¯ç·åå»çè©è°äŒïŒGMCïŒã«ãã£ãŠç®¡çãããŠããããã®çµç¹ã¯çè«äžã¯æ åå£äœã ããå®éã«ã¯æºæ¿åºæ©é¢ïŒã¯ã¡ã³ãŽïŒã®ææªã®æ§è³ªãæ¿åºéšéã®æ§è³ªããããŠè£œè¬æ¥çã®å·è¡æ©é¢ãšããŠã®æ§è³ªã䜵ãæã£ãŠããããã«èŠããã補è¬äŒç€Ÿã¯æ¿åºãæ¯é ããå»çæ©é¢ãæ¯é ãããããŠã©ãããè±åœã®å»åž«å èš±æ©é¢ã§ããç·åå»çè©è°äŒïŒGMCïŒãŸã§ãæ¯é ããŠããããã ã
50幎åãç·åå»çè©è°äŒïŒGMCïŒã¯æ¥æçŽã«ã¹ãã£ã³ãã«ãäžç¥¥äºã宿çã«æäŸããããšã§æªåé«ãã£ããGMCã¯ãè¬ç©ä¹±çšãæ£è ãšã®æ§çé¢ä¿ãçºèŠããå»åž«ã®å èš±å¥å¥ªãå°éãšããŠãããææãåºåè¡çºã§éé£ã§ããå»åž«ãæšçã«ããããšããã£ãã
ïŒããã§è£è¶³ãããšã1970幎代ãç§ã¯ãã³ããŒã ã§å·çããäžé£ã®å°èª¬ãåå ã§GMCã®æ³šç®ã济ã³ãã補è¬äŒç€Ÿããã®èŠæ ãåããŠGMCã¯ç§ã«æžç°¡ãéããå»åž«åç°¿ããã®é€åã瀺åãããåœæç§ã¯NHSã®äžè¬éæ¥å»ã§å人æ£è ã¯ããããå°èª¬ã¯ãã³ããŒã ã§å·çãããŠããããïŒGMCã«ã¯ãã¬ãŠããããã ãïŒãã®ä»¶ã¯ããã«åæãããããããããã¯GMCãä»ã®æ©äŒã«ç§ãæšçã«ããããšã劚ããªãã£ãã圌ãã¯è£œè¬äŒç€Ÿããã®èŠæ ãåããç§ã®ããåŠè¡çãªèäœââäŸãã°1975幎ã«åºçããããThe Medicine Menãââã«ç°è°ãå±ããã®ã§ããããã®æ¬ã§ç§ã¯è£œè¬æ¥çãšå»ççã®å¯æ¥ãªé¢ä¿ãæŽé²ããŠãããé·å¹Žã«ããããç§ã¯è£œè¬äŒç€Ÿããã®çµ¶ãéãªãèŠæ ãšèšŽèšã®æšçãšãªã£ãŠãããç§ã®åé¡ã¯ãèæžããµã³ããŒã»ã¿ã€ã ãºçŽã®ãã¹ãã»ã©ãŒãªã¹ãã«ç»å Žããèªè ãæ¡å€§ãå§ããé ããå¢å€§ããããã«æãããã
è¿å¹ŽãGMCïŒè±åœå»çè©è°äŒïŒã¯ãèªåŒµãããCOVID-19ãã³ãããã¯ãšç¡æå³ã§ãããªããæ¥µããŠå±éºãªCOVIDã¯ã¯ãã³ãç°åžžãªãŸã§ã«äžæ¹çã«æè·ããããšã§æªåé«ããªã£ãã
2020幎2æãš3æã«åœã®ãã³ãããã¯ãç±ççã«æšé²ãããéãç§ã¯å³åº§ã«COVIDéšåãããã ãšææãããå ¥æå¯èœãªããŒã¿ã¯ãæããã«åãªãå£ç¯æ§ã€ã³ãã«ãšã³ã¶ã®æ¹åçã«éããªããã®ã®å±éºæ§ããé¢é£ããŒã¿ã®è©äŸ¡ã«ãããŠäžé©åãªå®çžŸãæã€è ãã¡ã«ãã£ãŠé倧ã«èªåŒµãããããšãçããªã蚌æããŠãããè±åœã§ã¯æ¿åºèªèº«ã®å ¬åŒã¢ããã€ã¶ãŒãç§ã®èŠè§£ã«åæããCOVID-19ææã¯å£ç¯æ§ã€ã³ãã«ãšã³ã¶ä»¥äžã®å±éºæ§ã¯ãªããšåŠå®ããã圌ãã®å°éçå©èšã¯ãã²ã©ãå®çžŸãæã€æ°åŠè ã®å©èšãåªå ããŠç¡èŠãããããã ã
ç§ã¯1960幎代ãã補è¬äŒç€Ÿãšå»çè©æ¬ºã«ã€ããŠå·çããŠãããå»çè©æ¬ºã¯é ãããã§ãèŠæãããåœç¶ãªãããèªåŒµããããªã¹ã¯ã®èåŸã«ããå ±è¬è ãã¡ïŒç§ã¯æå³çã«ãå ±è¬è ããšããèšèã䜿ãïŒã¯ãç§ãã³ããéšåãããã ãšè¡šçŸããããšã«äžå¿«æã瀺ããïŒãã®ã¿ã€ãã«ã®åç»ã¯æ°æ¥ã§æ°çŸäžååçãããïŒããããŠç§ã¯ããã«ã¡ãã£ã¢ã§æªè æ±ããããåã®å ±éããªããããGMCïŒè±åœå»çè©è°äŒïŒã¯ç§ã®å èš±ãå¥å¥ªã§ããªãã£ãã圌ãã®è¡æ¿èŠåã«ããã°ãå€ãã®å»åž«ãšåæ§ãçŸåœ¹åŒéã«ããç§ã¯æ¢ã«å èš±ãè¿äžããŠããããã ããããçŸåœ¹ã®è¥æå»åž«ãã¡ã¯ã補è¬äŒç€Ÿã«æ¯é ãããå»çäœå¶ã®æãããŸãšãã«åããããšã«ãªã£ãã
äŸãã°ãNHSïŒè±åœåœæ°ä¿å¥ãµãŒãã¹ïŒã§å°æ¬ãããå€ç§å»ã ã£ãã¢ãããã»ã¢ãã£ã«å士ã®äºäŸãèããŠã¿ããã圌ã¯ã³ããè©æ¬ºãæ©æã«æ¹å€ããæ°å°ãªãå»åž«ã®äžäººã ã£ããïŒåŸã«æã ã«å ãã£ãä»ã®å»åž«ããã€ã¯ã»ã€ãŒãã³å士ã®ãããªç§åŠè ãã¡ã¯æè¿ããããïŒã¢ãã£ã«åå£«ãæ¿åºã®ã³ããæ¹éãæ¹å€ãããšãGMCã¯å èš±å¥å¥ªã§å¿ããââã€ãŸã圌ã¯å€ç§å»ãšããŠããããã¯ãããªãç«å Žã®å»åž«ãšããŠã蚺çã§ããªããªã£ãã®ã ã
仿¥ãªããã¢ãã£ã«å士ã¯å èš±ãå埩ã§ããŠããŸããã圌ã«èª²ãããã代åã¯èšãç¥ããŸããããããŠæã ã¯NHSã«èª²ãããã代åãå¿ããŠã¯ãªããŸãããä»®ã«åœŒããã®3幎éã§å¹Žé1,000ä»¶ã®æè¡ãè¡ãããšä»®å®ããã°ïŒæ±ºããŠéçŸå®çãªæ°åã§ã¯ãããŸããïŒã圌ã®è¿œæŸã¯æ°åäººã®æ£è ãå¿ èŠãªæè¡ãåããããªããªã£ãããšãæå³ããŸãã
ã¢ãã£ã«å»åž«ã¯å€ç«ããŠããªããè±åœã§ã¯ä»ã«ããèåç¡çšœã§æ£åœåäžå¯èœãªã³ããæ¿çãæ¹å€ããããã«å èš±ãå¥å¥ªãããå»åž«ãè€æ°ãããã¢ãã£ã«å»åž«ãå èš±å¥å¥ªåŠåã«å¯ŸããŠæ§èšŽããéãç§ã¯æ§èšŽè£å€æã®3人ã®è£å€å®ã«ãã¢ãã£ã«å»åž«ã®ä»£çãšããŠæžç°¡ãéä»ããã
以äžãç§ãéä»ããæžç°¡ã§ãïŒ
ãã£ã³ã²ãã³ã¹å€äºé£äžãããŒã³å€äºé£äžãããã«ãŠã§ã«å€äºé£äž
ããŒãã³ã»ã³ãŒã«ãã³ïŒå»åŠå£«ã»çåŠå士ïŒ
2023幎10æ23æ¥
æå
ç§ã¯åŒéãã鿥å»ã§ãããè±åœå»åž«äŒïŒGMCïŒã«ããã¢ãããã»ã¢ãã£ã«å»åž«ãžã®é人éçãã€æ®é ·ãªæ±ãã«æ€æ šããŠããè±åœäººå»åž«ã®äžäººã§ããããããç³ãæ·»ããã¹ãã§ãããããç§ã¯ã¢ãã£ã«å»åž«ãšé¢èã¯ãããŸãããåœŒã®æ±ããæ¹ã«å¿ãçããã®ã¯ãGMCã«ããäžåœãã€çäžå°œãªåŠéãžã®æžå¿µããã§ããã
ã¢ãã£ã«å»åž«ã«ä»£ãã£ãŠä»¥äžã®ç¹ãç³ãäžããããšæããŸãã
第äžã«ãè±åœå»åž«äŒïŒGMCïŒã¯è£œè¬äŒç€Ÿã«å€é¡ã®æè³ãè¡ã£ãŠããŸãããGMCãæ ªåŒãä¿æããŠããäŒæ¥ã®äžã€ã¯ãCOVID-19ã¯ã¯ãã³ã補é ããäŒæ¥ã§ãããã¢ã¹ãã©ãŒãã«ãªã©ã®ã¯ã¯ãã³ã¡ãŒã«ãŒã®è²¡åçæåã«å©å®³é¢ä¿ãæã€GMCããCOVID-19ããã³COVIDã¯ã¯ãã³ã«é¢é£ããå»åž«ã®è¡åãã©ã®ããã«å€æã§ããã®ã§ããããïŒã¯ã¯ãã³è£œé ã«è³éãæããŠããGMCã¯ãã¯ã¯ãã³è²©å£²ãä¿è·ããå©å®³é¢ä¿ãæããŠããããããã£ãŠãèªããè³éãæããäŒæ¥ã®åçå¯èœæ§ãæãªãå¯èœæ§ã®ããè¡åãåã£ãå»åž«ãæ²æãã¹ãã§ã¯ãããŸãããGMCã¯ãèªããçµæžçå©å®³é¢ä¿ãæã€è£œåãæ¹å€ããè ã眰ããŠããã®ã§ããå®éãGMCã¯å ¬è¡ã®å®è·è ãšããŠã®åœ¹å²ãæŸæ£ããè£œè¬æ¥çã®å·è¡æ©é¢ãžãšå€è³ªãããšç§ã¯äž»åŒµããŸãã
第äºã«ãGMCã®å¯Ÿå¿ã¯äžè²«æ§ãæ¬ ããŠãããCOVID-19ãã¯ã¯ãã³ã«ã€ããŠçºèšããä»ã®å»åž«ãã¡ã¯å»åž«åç°¿ããæ¹æ¶ãããŠããªãã
第äžã«ãã¢ãã£ã«å»åž«ãžã®é人éçãªåŠçœ°ã¯æ£è ã«ã被害ããããããã倱ããã3幎åã®éã圌ã幎é1,000ä»¶ã®æè¡ãè¡ããå¯èœæ§ãèæ ®ããã°ïŒæ±ºããŠéçŸå®çãªæ°åã§ã¯ãªãïŒããã®3幎åã®è³æ Œåæ¢ã¯3,500äººã®æ£è ãå¿ èŠãªæè¡ãåããããªãã£ãããšãæå³ãããã¢ãã£ã«å»åž«ã¯å°éçç¡èœãããã«ç»é²æ¹æ¶ãããããã§ã¯ãªãã
第åã«ã åœé£æ²ç« 第19æ¡ã¯ããã¹ãŠã®äººéã¯ãæèŠåã³è¡šçŸã®èªç±ã«å¯Ÿããæš©å©ãæããããšæèšããŠãããå»åž«ã®æš©å©ãå¶éããä»åã¯ååšããªããGMCã®æ±ºå®ã¯ãã®åºæ¬ç人暩ã«çã£åããåãããå»åž«ã¯ç«å Žãšèšç·Žããã«ç¹å¥ãªè²¬ä»»ãè² ããšã®äž»åŒµãããããããã¯åœé£æ²ç« ã匱ããã©ããã匷åãããã®ã§ãããå»åž«ã«ã¯äžæ£ããããšä¿¡ããæã声ãäžããç¹å¥ãªè²¬ä»»ãããããããŠèšããŸã§ããªããèšè«ã®èªç±ã¯ãå°ãã ãããšããããã«ã¯ãããªãã女æ§ããå°ãã ãåŠåš ããŠããããšèšããªãã®ãšåãã ãèšè«ã®èªç±ã¯å®å šã«ååšããããååšããªããã®ã©ã¡ããã§ãããå»åž«ãå»çäœå¶ãæ¹å€ã§ããªããšèšãã®ã¯ãéå æ¿æ²»å®¶ãæ¿åºãæ¹å€ã§ããªããšèšãã®ãšåããããç¡æå³ã§ãããGMCãåœé£æ²ç« ã«éåããŠããããšã¯çãããããªããå»åž«ã¯èªãã®èŠè§£ãå ¬ã«å ±æããæš©å©ããããå ¬è¡ã¯èª°ãä¿¡ããããæ±ºããæš©å©ãããã
第äºã«ãGMCã¯æ¿åºãšå»çæ©é¢ãåžžã«æ£ããæ¹å€ãè¶ è¶ããŠããã¹ãã ãšæ³å®ããŠãããããã¯å±éºãªãã³ã»ã³ã¹ã§ãããæ¿åºãšå»çæ©é¢ãå®å šã«èª€ãããã®çµææ£è ãå»åž«ãã¡ãçå®ã®ããã«ç«ã¡äžããåæ°ãæã€ãŸã§èŠããã äºäŸã¯ãæŽå²ãããã®ãŒããªããšãæ°å€ãèŠåºããããžã§ã³ã»ã¹ããŒå士ããŽã£ã¯ããªã¢å¥³çã«ã¯ãããã«ã ãæäžããéãç£å©Šã«éº»é ãæœãã¹ãã§ãªããšããå»ççã®åçºãå·»ãèµ·ãã£ãã黿°ããããçæ³ãçœè³ªåé€è¡ãè žç®¡ã®å€§èŠæš¡åé€ã¯å šãŠå»ççã®æ¿èªãåŸããåŸã«éé£ããããææ¡è ºãæ£åœãªçç±ãªãæåºãããã®ãå»ççã®ææ¥ã§ããããã®çµæãäœäººã®åäŸãåœãèœãšãããã¯èª°ã«ãããããªããå»ççãæšé²ãã誀ã£ãå»çæ £è¡ã«ãããå€ãã®æ£è ã«äžèŠãªå¿èæè¡ãæœãããŠãããå»ççã容èªãããã¯å¥šå±ãã誀ã£ãå»çæ £è¡ããã«ãäœçŸäžãã®æ£è ããã«ãããŒã«é žç³»è¬å€ããããŠãã³ãŸãžã¢ãŒãã³ç³»è¬å€ã«äŸåããããã«ãªã£ãã®ã ããããŠãã¢ãã£ã«å»åž«ãéé£ãã人ã ã®ãã¡ãåºã䜿çšãããã€ãŠæ¿èªãããŠããã¯ã¯ãã³æ¥çš®ããã°ã©ã ãç¡äŸ¡å€ã§å±éºã ãšéé£ãããŠããããšãããã£ããäœäººãç¥ã£ãŠããã ããããæŽå²ã¯ãå»ççãæ£ãããããééã£ãŠããããšã®ã»ããå€ãã£ãããšã瀺ããŠãããããè±åœå»åž«äŒïŒGMCïŒããæ¿åºãïŒè£œè¬æ¥çãšçµã³ã€ããŠããããšãç¥ãããŠããïŒå»ççãæ¹å€ããå»åž«ãæ¢ãããããªããæ±ºããŠè¯ãæ¹åã«ã¯å€ãããªãã ãããå»çå²ãããå°ãé¡ããšãå嚩宀ã®å¥³æ§ãã¡ã«é¢ããç ç©¶ã§å»çæ £è¡ãå€ããæ°çŸäžãšã¯èšãã¬ãŸã§ãæ°åã®åœãæã£ããŒã³ã¡ã«ãŽã§ã€ã¹å士ã®ãããªäººç©ã«åºäŒããåœç¶ãªããããŒã³ã¡ã«ã¯ã€ã¹å士ã¯å»ççããæ¿ããæ»æãåãããæŽå²ã瀺ãçŽãããªãçå®ã¯ãå»ççãåžžã«çå®ãæå§ããå©çãçãåãæšé²ããŠãããšããããšã ãäœãå€ãã£ãŠããªããå»ççã¯ä»ãªã广ã®ãªãå»çåŠçœ®ãæšé²ããäžå¯æ¬ ã ãéœåã®æªãçå®ãæå§ããŠãããGMCã®æ ¹æ¬çãªéã¡ã¯ãæ£è ã®çŠç¥ã§ã¯ãªãå»ççãžã®å¿ èª ãåªå ãã¹ãã ãšèããç¹ã«ãããšç§ã¯èããã
第å ã«ãçŸåšã®èšŒæ ã¯å»ççã®COVID-19ã«é¢ããå ¬åŒèŠè§£ãå®å šã«èåœã§ãã£ãããšã極ããŠæç¢ºã«ç€ºããŠãããå»ççãçºèšãå®è¡ããå šãŠã¯ã蚌æå¯èœãªã»ã©èª€ãã§ããå±éºã§ãã£ããè±åœå»åž«äŒãšãã®æ±ºå®ãæ¯æããè ãã¡ã¯ãå»ççãæ£ãããšæ³å®ããŠããããã ããçå®ã¯èª€ãã§ãã£ããGMCã蚌æ ã粟æ»ããŠããã°ãè±åœæ¿åºèªèº«ã®ç§åŠé¡§åå£ã2020幎3æã«COVID-19ã¯é倧ãªè åšã§ã¯ãªããšå€æããŠããäºå®ãç¥ã£ãŠããã¯ãã ãæ¿åºçµ±èšã瀺ãããã«ãCOVID-19ã«ããæ»è æ°ã¯æ¯å¹Žã€ã³ãã«ãšã³ã¶ã§æ»äº¡ãã人æ°ïŒäžå¯è§£ã«ãéœåããæ¶ãå»ã£ãçŸç ïŒãäžåããªãã£ãããšãèªèããŠããã¯ãã§ãããå®éãæããã«åç§°å€æŽãããã€ã³ãã«ãšã³ã¶ã«ããæ»äº¡è æ°ã¯ã2020幎ãš2021幎ã«ãããŠéå»ã®ç¹å®å¹Žãšæ¯ã¹ãŠå¢å ããŠããªãã£ããããã«ãããã¯ããŠã³ã瀟äŒçè·é¢ã®ç¢ºä¿ããã¹ã¯ççšãšãã£ãèåç¡çšœãªæ¿çã«ã¯ç§åŠçæ ¹æ ããªããäžå¿ èŠãã€å±éºã§ããã2022幎ã«é¡èãšãªãä»åŸæ°å¹Žéç¶ããšäºæž¬ãããæ»äº¡è æ°ã®å¢å ã®äžå ãšãªã£ãããšãä»ãæããã§ãããPCRæ€æ»ã¯æ¬æ¥ãã®ããã«äœ¿çšãããããšãæå³ãããŠããããçãã®äœå°ãªãã³ã€ã³æããšåçšåºŠã®äŸ¡å€ãããªãããšã蚌æãããŠãããåŠæ ¡ãäŒæ¥ã®ééãå®å šã«äžå¿ èŠã§ãããç倧ãã€é·æçãªæå®³ããããããããšã¯æããã ãããã«æªãããšã«ãCOVID-19ã¯ã¯ãã³ãé©åã«è©Šéšãããããšã¯äžåºŠããªããç®çãæããã®ã«é©ããŠãããããããŸã§åžå Žã«åºåã£ãäžã§æãå±éºã§èŽæ»æ§ã®é«ãå»è¬åã§ããããšã¯ãä»ãæçœã§ãããç¥æ§ããæ å ±éã®å»åž«ãç§åŠè ã«ãã£ãŠåºãèªããããŠãããé¢ä¿ãã補è¬äŒæ¥ãšã®ç¹ãããäž»ãªåå ã§ãæ¿åºãšå»çæ©é¢ã¯äžè¬åžæ°ãšå»çå°éè·ã誀ã£ãæ¹åã«å°ãããããã«ããããããããããã蚌æ ãããã«ãããããããæ¿åºé«å®ãã¡ãã£ã¢ã¯ããããã®åé¡ãå ¬ã®å Žã§ïŒãããã¯éå ¬éã®å Žã§ãïŒè°è«ããããšãé ãªã«æåŠãç¶ããŠããã
èªç±ã§é²æ©çãªç€ŸäŒã«ãããŠãäœå¶ãžã®æ¹å€ã¯ç ©ãããäžäŸ¿ãªãã®ãããããªãããæ±ºããŠæ€é²ã®å¯Ÿè±¡ãšãªãã¹ãã§ã¯ãªãã
以äž
æ¬å ·
ãŽã¡ãŒãã³ã»ã³ãŒã«ãã³
è£å€å®ãã¡ã¯ç§ã®æçŽã«è¿çãããããååšããèªããããšããªãã£ãããããŠã¢ãã£ã«åå£«ã¯æ§èšŽã§å蚎ã§ããªãã£ãã
ã¢ãã£ã«å士ã¯åœå±ãšã®éãã§çºçããæ³å»·è²»çšã«ããå€é¡ã®è² åµãæ±ããŠãããæ¯æŽãåžæãããæ¹ã¯ã以äžã®å£åº§ãžå¯ä»ãééã§ããïŒ
Mohammad I Adil
å£åº§çªå· 00109536
æ¯åºã³ãŒã 83-19-19
Royal Bank of Scotland, UK ISBN GB69RBOS83191900109536ãSwiftã³ãŒã RBOSGB2Lãã¢ãã£ã«å士ã®äºä»¶ã®è©³çްã¯ãã¡ããå士ãåµèšã¡ã³ããŒãåããäžçå»åž«é£çïŒWorld Doctor AllianceïŒã«ã€ããŠã¯ãã¡ããã芧ãã ããã
äžçäžã§å šãåãäºæ ãèµ·ããŠããŸããå èš±åœå±ãç§åŠç蚌æ ãç¡èŠããçå®ãäžçã«äŒããããšããå»åž«ãã¡ïŒäž»ã«SNSäžã§ïŒã眰ããŠããã®ã§ãããã®éç§åŠçãªããããšããã®çµæãåºãå ±ããããããšãçžãŸã£ãŠãçåãäžå®ãå ±æããäœå人ãã®å»åž«ãã¡ãæ²é»ã匷ããããŠããŸãã圌ããå èš±ãšçèšã倱ãããšãæããŠããã®ã§ãã蚺çå èš±ã®ãªãå»åž«ã¯ãç®ã®ãªãç çªæé€äººãã¿ã¯ã·ãŒã®ãªãé転æãšåããç¡åã§ããã
äžæ¹ã§é©ãã¹ãã¯ãæ£è ãé¡§ã¿ãäžèŠãã€å±éºãªè¬å€ã®æ¥çš®ãè³è³ã§åãå ¥ããå»åž«ãã¡ã«å¯ŸããGMCãå šãäœã®æªçœ®ãåã£ãŠããªãããã«èŠããããšã ãããã«ãã€ã³ãã¬çãå€§å¹ ã«äžåã35ïŒ ã®è³äžããèŠæ±ããŠã¹ãã©ã€ããè¡ããæ£è ãèŠæšãŠãŠããããé埳çã»å«ççã»è·æ¥ç矩åãç Žã£ãå»åž«ãã¡ã«å¯ŸããŠããGMCã¯çœ°ãäžããŠããªãã
GMCãã¢ãã£ã«å»åž«ã®å èš±ãå¥å¥ªããæ±ºå®ã¯ãæåããæ£åœåã§ããªããå»åž«ãå»çäœå¶ãæ¹å€ããŠã¯ãªããªããšèšãã®ã¯ãéå æ¿æ²»å®¶ãæ¿åºãæ¹å€ããŠã¯ãªããªããšèšãã®ãšåããããç¡æå³ã§ãããçºèšãçç±ã«å»åž«å èš±ãå¥å¥ªããå èš±åœå±ã¯ãåœé£æ²ç« ã«æããã«éåããŠãããåŒè·å£«ãè£å€å®ãããããªãå èš±æ©é¢ã«ãå人ã®åœé£æ²ç« ã«ããä¿è·æš©ãåŠå®ããããšã蚱容ã§ãããšæ£åœåã§ããã®ãã¯ãççŽã«èšã£ãŠç§ã«ã¯äžå¯è§£ã§ãããå»åž«ã¯èªãã®èŠè§£ãå ¬ã«å ±æããæš©å©ããããå ¬è¡ã¯èª°ãä¿¡ããããæ±ºããæš©å©ãããã
ã¡ãªã¿ã«ç¹çãã¹ãã¯ã2020å¹Žåæ¥ããæ¿åºã補è¬äŒæ¥ãæ¯æããå»åž«ãã¡ãå ¬ã®å Žã§è°è«ããããšãé ãªã«æã¿ãäž»æµïŒäŒæ¥ç³»ïŒã¡ãã£ã¢ãåœã®ãã³ãããã¯å ±éã«ãããŠå®å šã«åã£ãäžæ¹çãªå§¿å¢ãåã£ãããšã ãBBCã¯ãæ£èª€ã«é¢ããããã¯ã¯ãã³äŸ¡å€ãçåèŠãã人ç©ãžã®ã€ã³ã¿ãã¥ãŒãäžåè¡ããªããšãŸã§è¡šæãããç§ã¯ã¯ã¯ãã³æ¯æè ã«å¯Ÿããå šåœçæŸéã§ã®å ¬éèšè«ãç¹°ãè¿ãæãã§ãããããã®ææŠãåãå ¥ããèªä¿¡ãåæ°ãæã£ãè ã¯äžäººãããªãã£ãã
第äºã«ãGMCïŒè±åœå»çè©è°äŒïŒã¯æ¿åºãšå»ççãåžžã«æ£ããæ¹å€ãè¶ è¶ããŠãããšæ³å®ããŠãããããã¯å±éºãªãã³ã»ã³ã¹ã ãæ¿åºãšå»ççãå®å šã«èª€ãããã®çµææ£è ãå»åž«ãçå®ã®ããã«ç«ã¡äžããåæ°ãæã€ãŸã§èŠããã äºäŸã¯ãæŽå²ãããã®ãŒããªããšãæ°å€ãååšããããžã§ã³ã»ã¹ããŒå士ããŽã£ã¯ããªã¢å¥³çã«ã¯ãããã«ã ãæäžããéãç£å©Šãžã®éº»é æäžã¯äžé©åãšã®å»ççã®åçºã§éšåãšãªã£ãã黿°ããããçæ³ãçœè³ªåé€è¡ãè žç®¡ã®å€§éåé€ã¯å šãŠå»ççã®æ¿èªãåŸããåŸã«éé£ããããææ¡è ºãæ£åœãªçç±ãªãæåºãããã®ãå»ççã®ææ¥ã§ããããã®çµæãäœäººã®åäŸãåœãèœãšãããã¯èª°ã«ãããããªããå»ççãæšé²ãã誀ã£ãå»çæ £è¡ã«ãããå€ãã®æ£è ã«äžèŠãªå¿èæè¡ãæœãããŠãããå»ççã容èªãããã¯å¥šå±ãã誀ã£ãå»çæ £è¡ããã«ãäœçŸäžãã®æ£è ããã«ãããŒã«é žç³»è¬å€ããããŠãã³ãŸãžã¢ãŒãã³ç³»è¬å€ã«äŸåããããã«ãªã£ãã®ã ããããŠãã¢ãã£ã«å»åž«ãéé£ãã人ã ã®ãã¡ãåºã䜿çšãããã€ãŠæ¿èªãããŠããã¯ã¯ãã³æ¥çš®ããã°ã©ã ãç¡äŸ¡å€ã§å±éºã ãšéé£ãããŠããããšãããã£ããäœäººãç¥ã£ãŠããã ãããã
æŽå²ã¯ãå»ççãæ£ãããããééã£ãŠããããšã®ã»ããå€ãã£ãããšã瀺ããŠãããããGMCïŒè±åœå»åž«äŒïŒãå»åž«ã«ããæ¿åºãå»ççïŒè£œè¬æ¥çãšçµã³ã€ããŠããããšãç¥ãããŠããïŒãžã®æ¹å€ãæ¢ãããããªããæ±ºããŠè¯ãæ¹åã«ã¯å€ãããªãã ããã
å»çå²ãããå°ãé¡ããšãå嚩宀ã®å¥³æ§ãã¡ã«é¢ããç ç©¶ã§å»çæ £è¡ãå€ããæ°çŸäžãšã¯èšãã¬ãŸã§ãæ°åã®åœãæã£ããŒã³ã¡ã«ã¯ã€ã¹å士ã®ãããªäººç©ã«åºäŒããåœç¶ãªããããŒã³ã¡ã«ã¯ã€ã¹å士ã¯å»ççããæ¿ããæ»æãåãããç§ã®èæžãå»çç°ç«¯è ãã¡ãã«ã¯ãããã«å€ãã®äºäŸãèšãããŠããã
åŠå®ã§ããªãçå®ã¯ãæŽå²ã瀺ãããã«å»ççã¯åžžã«çå®ãé èœããå©çãçãåãæšé²ããŠãããšããããšã ãäœãå€ãã£ãŠããªããå»ççã¯ä»ãªã广ã®ãªãå»çåŠçœ®ãæšå¥šããäžå¯æ¬ ã ãéœåã®æªãçå®ãé èœããŠãããGMCïŒè±åœå»çè©è°äŒïŒã®æ ¹æ¬çãªéã¡ã¯ãæ£è ã®çŠç¥ã§ã¯ãªãè£œè¬æ¥çãšå»ççãžã®å¿ èª ãåªå ãã¹ãã ãšèããç¹ã«ãããšç§ã¯èããã
第äžã«ãããããããçŽæ¥çã«èšãã°ãçŸåšã®èšŒæ ã¯å»ççã®COVID-19ã«é¢ããå ¬åŒèŠè§£ãå®å šã«èåœã§ãã£ãããšã極ããŠæç¢ºã«ç€ºããŠãããå»ççãçºèšãå®è¡ããå šãŠã¯èª€ãã§ããå±éºã§ãã£ããè±åœå»åž«äŒïŒGMCïŒãšãã®æ±ºå®ãæ¯æããè ãã¡ã¯ãå»ççãæ£ãããšæ³å®ããŠããããã ã
ãã圌ãã蚌æ ãæ³šææ·±ãæ€èšŒããŠããã°ãè±åœæ¿åºèªèº«ã®ç§åŠé¡§åå£ã2020幎3æã«COVID-19ã¯é倧ãªè åšã§ã¯ãªããšå€æããŠããããšãç¥ã£ãŠããã¯ãã ãæ¿åºçµ±èšã瀺ãããã«ãCOVID-19ã«ããæ»è æ°ã¯æ¯å¹Žã€ã³ãã«ãšã³ã¶ã§æ»äº¡ãã人æ°ïŒäžå¯è§£ã«ãéœåããå§¿ãæ¶ããçŸæ£ïŒãäžåããªãã£ãããšãèªèããŠããã¯ãã§ãããå®éãæããã«åç§°å€æŽãããã€ã³ãã«ãšã³ã¶ã«ããæ»äº¡è æ°ã¯ã2020幎ãš2021幎ã«ãããŠéå»ã®ç¹å®å¹Žãšæ¯ã¹ãŠå¢å ããŠããªãã£ããããã«ãããã¯ããŠã³ã瀟äŒçè·é¢ã®ç¢ºä¿ããã¹ã¯ççšãšãã£ãèåç¡çšœãªæ¿çã«ã¯ç§åŠçæ ¹æ ããªããäžå¿ èŠãã€å±éºã§ããã2022幎ã«é¡èãšãªãä»åŸæ°å¹Žéç¶ããšäºæž¬ãããæ»äº¡è æ°ã®å¢å ã®äžå ãšãªã£ãããšãä»ãæããã§ãããPCRæ€æ»ã¯åœåãããã®çšéãæ³å®ãããŠããããçãã®äœå°ãªãã³ã€ã³æããšåçšåºŠã®äŸ¡å€ãããªãããšã蚌æãããŠãããåŠæ ¡ãäŒæ¥ã®ééãå®å šã«äžå¿ èŠã§ãããç倧ãã€é·æçãªæå®³ããããããããšã¯æããã ã
ããã«æªãããšã«ãç¥æ§ããæ å ±éã®å»åž«ãç§åŠè ãã¡ã®éã§åºãèªããããŠããããã«ãCOVID-19ã¯ã¯ãã³ã¯é©åã«è©Šéšãããããšããªããç®çãæããã®ã«é©ããŠãããããããŸã§åžå Žã«åºåã£ãäžã§æãå±éºã§èŽæ»æ§ã®é«ãå»è¬åã§ããããšãä»ãæçœã§ãããé¢ä¿ãã補è¬äŒæ¥ãšã®ç¹ãããäž»ãªåå ã§ãæ¿åºãšå»çæ©é¢ã¯äžè¬åžæ°ãšå»çå°éè·ã誀ã£ãæ¹åã«å°ããã
æåŸã«ãGMCãã¢ãã£ã«å»åž«ãCOVID-19ããã³ã¯ã¯ãã³ã«é¢ããå ¬åŒèŠè§£ãæ¹å€ããä»ã®å»åž«ãã¡ã«å¯ŸããŠããããªãè£å®ãäžãã¹ãã§ã¯ãªãã£ããããäžã€ã®è¡æçãªçç±ãããã
é©ãã¹ãããšã«ãè±åœå»åž«äŒïŒGMCïŒèªäœã極ããŠäžé©åãªè¡åãåã£ãŠããããã«æãããããã®æ²æåŠåã¯ä»ã確å®ã«çåèŠãããã¹ãã ã
è±åœå»åž«äŒïŒGMCã¯ç§ã®èŠè§£ã§ã¯ãè±åœã«ãããæ£è ã®äºå€§æµã®äžæ¹ã§ãããããäžæ¹ã¯è±åœå»åž«äŒïŒBMAïŒã ïŒã¯ããã¡ã¹ãããŒãã»é£²æäŒæ¥ã«100äžãã³ãè¿ããæè³ããŠãããããã«æªãããšã«ãå»åž«ã®ç»é²æããåŸãå€é¡ã®è³éã補è¬äŒç€Ÿã«æè³ããŠããããããŠãGMCãæ ªåŒãä¿æããŠããäŒæ¥ã®äžã€ããCOVID-19ã¯ã¯ãã³ã補é ããŠããäŒæ¥ã®äžã€ã ã£ãã®ã ã
ã¢ã¹ãã©ãŒãã«ã®ãããªã¯ã¯ãã³ã¡ãŒã«ãŒã®çµæžçæåã«å©å®³é¢ä¿ãæã€GMCããæ°åã³ãããŠã€ã«ã¹ãã¯ã¯ãã³æ¥çš®ã«é¢ããå»åž«ã®è¡åãã©ã倿ã§ãããšããã®ãïŒ
ç§ã«ã¯äžå¯èœã«æããã
åœã®ãã³ãããã¯ãšæå®³ãªæ°åã³ããã¯ã¯ãã³ãæ¹å€ããããã«å èš±ãå¥å¥ªãããå»åž«ã¯ãGMCãæããã«ãæ±æããããŠãã以äžãçŽã¡ã«åŸ©è·ãããã¹ãã ãšèããã
ã¯ã¯ãã³è£œé ã«è³éãæããŠããGMCã«ã¯ãã¯ã¯ãã³è£œé ãä¿è·ããå©å®³é¢ä¿ããããšèšããã ããããããã£ãŠãèªããè³éãæããäŒæ¥ã®åçå¯èœæ§ãæãªãå¯èœæ§ã®ããè¡åãåã£ãå»åž«ãæ²æãã¹ãã§ã¯ãªãã
GMCã¯ãèªèº«ãééçå©å®³é¢ä¿ãæã€è£œåãæ¹å€ããè ã眰ããè£å€å®ã«äŸãããããå®éãGMCãšãã®èšå€§ãªæ°ã®é«çµŠåãã§ãæã«å²æ ¢ã«èŠããäºåå±ãã¡ã¯ãå ¬è¡ã®å®è·è ãšããŠã®åœ¹å²ãæŸæ£ããè£œè¬æ¥çã®å·è¡æ©é¢ãšåãããšç§ã¯äž»åŒµããã
æ¿åºãšå»çäœå¶ã®èª€ããçç Žããè±ç¥ãæã£ãå»åž«ãã¡ã¯ã眰ã§ã¯ãªãç§°è³ã«å€ããã
声ãäžããåæ°ãæã£ãè ãã¡ã¯ç§°è³ãããã¹ãã§ãããçŽæããã广ãçºæ®ããå€ãã®æ»ãšç ãããããããã¯ã¯ãã³ãã®æšé²è ã§ã¯ãªãã圌ããããç§°ããããã¹ãååšã ã
èªç±ã§é²æ©çãªç€ŸäŒã«ãããŠãäœå¶ãžã®æ¹å€ãæ€é²ã®å¯Ÿè±¡ãšãªãã¹ãã§ã¯ãªãã
ç§ã®çµè«ã¯ãè±åœå»åž«äŒïŒGMCïŒã¯ç®çãæããèœåããªããçŽã¡ã«å»æ¢ãããã¹ãã ãšããäžç¹ã«å°œãããç¬ç»é²èšŒãçºè¡ããè³æ ŒãããªãããŸããŠãå»åž«å èš±ã®ç®¡çãè¡ãèœåãªã©å°åºåãã£ãŠããªããå ¬è¡ãä¿è·ãããšããæ¬æ¥ã®ä»»åãæ ãããããæ£è ã®å©çãããè£œè¬æ¥çã®å©çãåªå ããŠè¡åããŠããããã«æãããã
äžçã®ä»ã®å èš±æ©é¢ã調æ»ããã°ãåæ§ã«å ¬è¡ãè£åã£ãŠãããšå€æããå¯èœæ§ããããããããåæ§ã«èª¿æ»ãããããšãæãã